A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol

INTRODUCTION: A drawback of gonadotropin-releasing hormone (GnRH) antagonist protocols in in vitro fertilization (IVF) is that they have limited flexibility in cycle programming. This proof of concept study explored the efficacy of a single-dose, long-acting GnRH antagonist IVF protocol. Trial regis...

Descripción completa

Detalles Bibliográficos
Autores principales: Papanikolaou, Evangelos G., Yarali, Hakan, Timotheou, Evi, Grynberg, Michael, Zafeiratis, Odysseas, Tournaye, Herman, Najdecki, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839166/
https://www.ncbi.nlm.nih.gov/pubmed/29545772
http://dx.doi.org/10.3389/fendo.2018.00025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839166/
https://www.ncbi.nlm.nih.gov/pubmed/29545772
http://dx.doi.org/10.3389/fendo.2018.00025

Ejemplares similares